ATH434 Preserves Sense of Smell, Aids Neurons in Parkinson's Mouse Model | Oral Therapy Showing Neuroprotective Potential

ATH434, Alterity Therapeutics’ experimental oral therapy, prevented a loss in the sense of smell — an early and common symptom of Parkinson’s disease — in a mouse model, and helped to preserve nerve cells and restore motor skills in older animals, a study showed. These findings add to those of previous work in other mouse models, […]










See full article ATH434 Preserves Sense of Smell, Aids Neurons in Parkinson's Mouse Model | Oral Therapy Showing Neuroprotective Potential by Pet News 2Day


#SmallPetsNews